Streetbeat News

Products Services

BAVA

KM Biologics

The WHO has received its first expression of interest for emergency use listing from a Mpox diagnostics manufacturer. WHO officials also discussed polio vaccination plans in Gaza and confirmed applications from Bavarian Nordic and KM Biologics for Mpox vaccines emergency use listing, with 230,000 doses available for Congo.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:55 pm

LLY

NVO

Novo Nordisk's semaglutide, marketed as Wegovy and Ozempic, shows promise in reducing heart failure complications, with a 31% reduction in cardiovascular events. However, it is not yet approved for heart failure outcomes in the US. The study also highlights potential in treating other conditions like cancer. Novo Nordisk's stock saw a slight increase following the news.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:54 pm

ALNY

BBIO

PFE

Alnylam Pharmaceuticals' stock fell after presenting detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardiomyopathy. Despite positive data on mortality reduction, the stock dropped 5.9%.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:51 pm

LMT

Lockheed Martin has resumed F-35 jet deliveries to the U.S. military, but the U.S. government is withholding $5 million per jet until a technology upgrade is completed. This impacts Lockheed's profit margins, as the F-35 program is a significant part of their sales. The company aims to deliver 100 jets this year and over 150 by 2025.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:46 pm

NVDA

Nvidia reported a 122% increase in Q2 revenues, reaching $30 billion, surpassing expectations. Despite strong financials, Nvidia's stock fell 6% in after-hours trading, likely due to high market expectations. The company plans to launch the Blackwell chip in Q4, expected to boost revenue further.

Portfolio Pulse from Zaheer Anwari

August 30, 2024 | 1:44 pm

ALNY

Alnylam Pharmaceuticals reported a typo in their presentation that misstated the benefits of their heart drug. This error was clarified during a company call.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:42 pm

AAL

AAPL

BRK

DAL

LUV

UAL

Warren Buffett's Berkshire Hathaway reached a $1 trillion market cap milestone, marking it as the first non-tech U.S. company to do so. The article highlights Buffett's investment journey, including significant investments in Coca-Cola, Geico, and Apple, and his decision to sell airline stocks during the pandemic.

Portfolio Pulse from Chris Katje

August 30, 2024 | 1:38 pm

DELL

SCWX

Dell Technologies Inc. shares rose after reporting better-than-expected Q2 results, with a 9% revenue increase and strong AI momentum. Dell is considering selling SecureWorks to reduce debt. B of A Securities raised Dell's price target to $155. Dell shares are up 44% this year.

Portfolio Pulse from Erica Kollmann

August 30, 2024 | 1:37 pm

KARS

KGRN

NIO

NIO Inc. shares are trading higher due to a surge in deliveries, driven by improvements in its Battery as a Service (BaaS) offering. Over 70% of users have opted for battery rental, reducing initial purchase costs and monthly fees. NIO's deliveries have doubled since the BaaS policy update in March.

Portfolio Pulse from Nabaparna Bhattacharya

August 30, 2024 | 1:20 pm

BBIO

BridgeBio Pharma shares rise following Alnylam Pharmaceuticals' positive data from the HELIOS-B Phase 3 study of vutrisiran. BridgeBio's ATTR-CM therapy, acoramidis, is under FDA priority review with a decision expected by November 29.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:07 pm